Aureus Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Aureus Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-168,343	Closed	-$9.16M	–	181
2019 Q4	$9.16M	Sell	168,343 -699	-0.4%	-$34.6K	1.02%	32
2019 Q3	$7.05M	Buy	169,042 +10,290	+6%	+$435K	0.88%	33
2019 Q2	$6.95M	Sell	158,752 -300	-0.2%	-$16.9K	0.86%	33
2019 Q1	$8.19M	Sell	159,052 -2,880	-2%	-$124K	1.08%	32
2018 Q4	$5.99M	Sell	161,932 -6,888	-4%	-$248K	0.94%	33
2018 Q3	$6.34M	Buy	168,820 +26,200	+18%	+$964K	0.81%	36
2018 Q2	$5.64M	Buy	142,620 +6,740	+5%	+$214K	0.77%	36
2018 Q1	$3.5M	Buy	+135,880	New	+$4.06M	0.53%	41

Other funds holding BHVN

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Aureus Asset Management's BHVN Position: Q1 2020 in Review

Aureus Asset Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q1 2020, closing a stake of 168,343 shares — an estimated $9.16M sold.

Aureus Asset Management first reported a position in BHVN in Q1 2018 and held it in 8 quarters. The position peaked at $9.16M in Q4 2019. 175 funds tracked by Wall St. Rank hold BHVN as of Q1 2020.

Aureus Asset Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q1 2020 after selling out during the quarter.
Aureus Asset Management sold 168,343 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2020, an estimated $9.16M.
Aureus Asset Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2018 and held it in 8 quarters.
Aureus Asset Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $9.16M in Q4 2019.
175 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2020.

Based on Aureus Asset Management's 13F filing for Q1 2020, filed 14 May 2020.